MedPath
FDA Product

Atovaquone

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Atovaquone

66689-062

Regulatory Information

66689-062

ANDA202960

C73584

February 24, 2023

USA

These highlights do not include all the information needed to use ATOVAQUONE ORAL SUSPENSION safely and effectively. See full prescribing information for ATOVAQUONE ORAL SUSPENSION. ATOVAQUONE oral suspensionInitial U.S. Approval: 1992

HUMAN PRESCRIPTION DRUG LABEL

8

Company Information

VistaPharm, LLC

116743084

Active Ingredients

ATOVAQUONE

Quantity: 750 mg in 5 mL

Code: Y883P1Z2LT

Class Code: ACTIB

BENZYL ALCOHOL

Code: LKG8494WBH

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

SACCHARIN SODIUM

Code: SB8ZUX40TY

Class Code: IACT

POLOXAMER 188

Code: LQA7B6G8JG

Class Code: IACT

XANTHAN GUM

Code: TTV12P4NEE

Class Code: IACT

ALCOHOL

Code: 3K9958V90M

Class Code: IACT

TRIACETIN

Code: XHX3C3X673

Class Code: IACT

PROPYLENE GLYCOL

Code: 6DC9Q167V3

Class Code: IACT

Active Moieties

ATOVAQUONE

Code: Y883P1Z2LT

© Copyright 2025. All Rights Reserved by MedPath